Login / Signup

Twelve-month risk of thromboembolic events in COVID-19 hospital survivors in Scotland.

James FarrellA B DochertyMathew ThorpeC A ShawEwen M HarrisonNazir I Lone
Published in: Anaesthesia (2022)
Keyphrases
  • coronavirus disease
  • sars cov
  • young adults
  • healthcare
  • acute care
  • atrial fibrillation
  • adverse drug
  • respiratory syndrome coronavirus